A fast growing international specialist in Molecular Nuclear Medication.

The company has particular expertise in molecular imaging and nuclear medication diagnostics for scientific and pre-clinical imaging, and radionuclide therapy. Its customers add a number of key international nuclear medicine companies. This all-share agreement demonstrates our confidence in AAA's very long term strategy and we are delighted to really have the opportunity to be considered a right part of that. African-American women’s magazines are more likely to encourage crash diets and reliance on faith to lose excess weight, while mainstream women’s periodicals focus more on evidence-based diet strategies, based on the scholarly study by UI researcher Shelly Campo, published in a recently available issue of the journal Health Communication.AMDL submits data to FDA for clearance to market its diagnostic check to monitor colorectal tumor patients AMDL, Inc., marketing expert and developer of exams for the first detection of cancers and other serious illnesses, today that it has filed with the U announced.S. Food & Medication Administration for clearance to market its unique, proprietary DR-70 ELISA tumor marker check for use as an aid in monitoring sufferers previously identified as having colorectal cancer.